Human alveolar echinococcosis-global, regional, and national annual incidence and prevalence rates.

IF 10.9 1区 医学 Q1 INFECTIOUS DISEASES
Britta Lundström-Stadelmann, Ali Rostami, Caroline F Frey, Paul R Torgerson, Seyed Mohammad Riahi, Kimia Bagheri, Marc Kaethner, Anja Lachenmayer, Guido Beldi, Robin B Gasser, Andrew Hemphill
{"title":"Human alveolar echinococcosis-global, regional, and national annual incidence and prevalence rates.","authors":"Britta Lundström-Stadelmann, Ali Rostami, Caroline F Frey, Paul R Torgerson, Seyed Mohammad Riahi, Kimia Bagheri, Marc Kaethner, Anja Lachenmayer, Guido Beldi, Robin B Gasser, Andrew Hemphill","doi":"10.1016/j.cmi.2025.01.034","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Alveolar echinococcosis (AE) of humans is a disease caused by the larval (metacestode) stage of the 'fox tapeworm' Echinococcus multilocularis. AE primarily affects the liver and, like cancer, can spread to surrounding or distant organs. Its slow progression and resemblance to malignant tumours emphasise the critical importance of early detection and intervention, as there is no highly effective vaccine against AE. Although recognised as a neglected disease, there has been no recent, comprehensive review of the distribution, incidence and prevalence of AE in humans around the world.</p><p><strong>Objectives: </strong>To estimate the global, regional, and national annual incidence rates and prevalences of human AE in endemic countries.</p><p><strong>Sources: </strong>Incidence and prevalence data were obtained from published articles from 1980 to 2024, accessible via public databases.</p><p><strong>Content: </strong>This article provides a brief background on E. multilocularis, its biology and impact; reviews the geographic distribution and incidence of AE; and gives a perspective on the prevention and control of this neglected disease in humans.</p><p><strong>Implications: </strong>The AE burden in humans is substantial and emphasises the need for enhanced public awareness, surveillance, prevention, and control, particularly in under-resourced communities to mitigate the health, economic, and psychological impact of AE.</p>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cmi.2025.01.034","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Alveolar echinococcosis (AE) of humans is a disease caused by the larval (metacestode) stage of the 'fox tapeworm' Echinococcus multilocularis. AE primarily affects the liver and, like cancer, can spread to surrounding or distant organs. Its slow progression and resemblance to malignant tumours emphasise the critical importance of early detection and intervention, as there is no highly effective vaccine against AE. Although recognised as a neglected disease, there has been no recent, comprehensive review of the distribution, incidence and prevalence of AE in humans around the world.

Objectives: To estimate the global, regional, and national annual incidence rates and prevalences of human AE in endemic countries.

Sources: Incidence and prevalence data were obtained from published articles from 1980 to 2024, accessible via public databases.

Content: This article provides a brief background on E. multilocularis, its biology and impact; reviews the geographic distribution and incidence of AE; and gives a perspective on the prevention and control of this neglected disease in humans.

Implications: The AE burden in humans is substantial and emphasises the need for enhanced public awareness, surveillance, prevention, and control, particularly in under-resourced communities to mitigate the health, economic, and psychological impact of AE.

人类肺泡包虫病-全球,地区和国家年发病率和流行率。
背景:人类肺泡棘球蚴病(AE)是一种由“狐绦虫”多房棘球绦虫的幼虫期引起的疾病。AE主要影响肝脏,像癌症一样,可以扩散到周围或远处的器官。它的缓慢进展和与恶性肿瘤的相似性强调了早期发现和干预的重要性,因为目前还没有针对AE的高效疫苗。虽然被认为是一种“被忽视的疾病”,但最近没有对世界各地人类AE的分布、发病率和流行率进行全面的审查。目的:估计全球、区域和国家的年发病率(air)和流行国家的人类AE患病率。资料来源:发病率和流行率数据来自1980年至2024年2月发表的文章,可通过公共数据库获取。内容:简要介绍了多房棘球蚴的研究背景、生物学及其影响;综述了AE的地理分布和发病率;并提出了预防和控制这种被忽视的人类疾病的观点。影响:人类的AE负担是巨大的,强调需要加强公众认识、监测、预防和控制,特别是在资源不足的社区,以减轻AE对健康、经济和心理的影响。布雷塔Lundström-Stadelmann,临床微生物感染2024;XX:XXX©2025作者。由爱思唯尔有限公司代表欧洲临床微生物和传染病学会出版。这是一篇基于CC BY-NC-ND许可(http://creativecommons.org/licenses/by-nc-nd/4.0/)的开放获取文章。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
25.30
自引率
2.10%
发文量
441
审稿时长
2-4 weeks
期刊介绍: Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信